Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
We are delighted by Ajay’s return to the Board of Invivyd as the company prepares to take the next step forward in scaling the medical benefit from its core technologies. Invivyd has rapidly ...
Becker's Spine Review5h
Spinal cord stimulators: 3 years of advances
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Le Lézard12h
CAR T-Cell Therapy Market Size To Reach 27.5 Billion by 2033 Owing to Rising Awareness and Favourable Reimbursement Policies Says Astute Analytica
The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, ...
New York Magazine6h
Why Are Some Visa and Green-Card Holders Being Detained and Deported?
There have been some harrowing reports about foreign nationals detained and deported amid Trump’s immigration crackdown. Here ...
Le Lézard14h
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
CollPlant Biotechnologies , or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...